Assessment of the efficacy of in vivo CFTR protein replacement therapy in CF mice

Human Gene Therapy

Volumn 9, Issue 4, 1998, Pages 521-528

  Ramjeesingh, Mohabir ^a   Huan, Ling Jun ^a   Wilschanski, Michael ^a,b,g   Durie, Peter ^b,g   Li, Canhui ^a   Gyomorey, Katalin ^a,f   Wang, Yanchun ^a   Kent, Geraldine ^e   Tanswell, Keith A ^c,g   Cutz, Ernest ^d,g   Ackerley, Cameron ^d   Bear, Christine E ^a,f,h  

^a Div of Cell Biology   (Canada)

^b Div of Gastrointestinal Research   (Canada)

^c Research Division   (Canada)

^d Laboratory Medicine Program   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE CHANNEL; LIPOSOME; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APICAL MEMBRANE; ARTICLE; CHLORIDE TRANSPORT; CONTROLLED STUDY; CYSTIC FIBROSIS; ELECTRON MICROSCOPY; EPITHELIUM CELL; GENE MUTATION; GENE THERAPY; IMMUNOGOLD STAINING; INFLAMMATION; INTRANASAL DRUG ADMINISTRATION; ION TRANSPORT; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NOSE MUCOSA; POTENTIAL DIFFERENCE; PROTEIN LOCALIZATION;

ANIMALIA;

EID: 17344367730     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.4-521     Document Type: Article

References (11)

1. ANDERSON, M., BERGER, H.A., RICH, D.P., GREGORY, R.J., SMITH, A.E., and WELSH, M.J. (1991). Nucleoside triphosphates are required to open the CFTR chloride channel. Cell 67, 775-784.
2. BEAR, C.E., LI, C., KARTNER, N., BRIDGES, R.J., JENSEN, T.J., RAMJEESINGH, M., and RIORDAN, J.R. (1992). Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 68, 809-818.
3. DONG, J.-Y., WANG, D., VAN GINKEL, F.W., PASCUAL, D.W., and FRIZZELL, R.A. (1996). Systemic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector. Hum. Gene Ther. 7, 319-331.
4. DORIN, J.R., FARLEY, R., WEBB, S., SMITH, S.N., FARINI, E., DELANEY, S.J., WAINWRIGHT, B.J., ALTON, E.W., and PORTEOUS, D.J. (1996). A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction. Gene Ther. 3, 797-801.
5. DRUMM, M.L., POPE, H.A., CLIFF, W.H., ROMMENS, J.M., MARVIN, S.A., TSUI, L.C., COLLINS, F.S., FRIZZELL, R.A., and WILSON, J.M. (1990). Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell 62, 1227-1233.
6. FAN, Z., and MALIELSKI, J.C. (1997). Anionic phospholipids activate ATP-sensitive potassium channels. J. Biol. Chem. 272, 5388-5395.
7. GILL, D.R., SOUTHERN, K.W., MOFFORD, K.A., SEDDON, T., HUANG, L., SORGI, F., THOMSON, A., MACVINISH, L.J., RATCLIFF, R., BILTON, D., LANE, D.J., LITTLEWOOD, J.M., WEBB, A.K., MIDDLETON, P.G., COLLEDGE, W.H., CUTHBERT, A.W., EVANS, M.J., HIGGINS, C.F., and HYDE, S.C. (1997). A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 4, 199-209.
8. GOLDMAN, M.J., ANDERSON, G.M., STOLZENBERG, E.D., KARI, U.P., ZASLOFF, M., and WILSON, J.M. (1997). Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88, 553-560.
9. GRUBB, B.R., PICKLES, R.J., YE, H., YANKASKAS, J.R., VICK, R.N., ENGELHARDT, J.F., WILSON, J.M., JOHNSON, L.G., and BOUCHER, R.C. (1994). Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 371, 802-806.
10. WILSCHANSKI, M.A., ROZMAHEL, R., BEHARRY, S., KENT, G., LI, C., TSUI, L.C., DURIE, P., and BEAR, C.E. (1996). In vivo measurements of ion transport in long-living CF mice. Biochem. Biophys. Res. Commun. 219, 753-759.
11. ZABNER, J., COUTURE, L.A., GREGORY, R.J., GRAHAM, S.M., SMITH, A.E., and WELSH, M.J. (1993). Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75, 207-216.